Evaluating how light affects neurological, psychiatric, and eye conditions
Official title: Study of the Photomotor Reflex to Evaluate the Role of the Non-visual Effects of Light in Neurological, Psychiatric and Ophthalmological Pathologies
Run by University Hospital, Strasbourg, France · NCT03811964 · Data updated 2026-11-12
This study is testing how different types of light can affect mood, sleep, and brain health in people with various conditions, as well as in healthy individuals.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 726 (estimated) |
| Sponsor | University Hospital, Strasbourg, France Academic / other |
| Locations | 1 site (Strasbourg) |
| Status | Recruiting |
| Started | January 22, 2020 |
| Main results expected | January 2028 |
| Study ends | February 2028 |
| Registry record updated | August 20, 2026 |
| Trial ID | NCT03811964 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 and older with sleep-wake disorders, neurological or psychiatric pathologies affecting sleep, ophthalmological conditions impacting photoreception, or healthy individuals for comparison.
✕Probably not a fit
Patients with significant vision loss due to conditions like Age-Related Macular Degeneration or cataracts may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the non-visual effects of light on various health conditions, including sleep disorders, neurological, psychiatric, and ophthalmological pathologies. It aims to understand how light influences behavior, mood, cognition, and sleep through specific light exposures. By examining these effects, the study seeks to establish new therapeutic applications for patients suffering from these conditions. Participants will be grouped based on their specific health issues or as healthy controls to assess the varying impacts of light exposure.
Why it matters
Potential benefit: If successful, this study could lead to new light-based therapies for managing sleep and mood disorders in patients with neurological, psychiatric, and ophthalmological conditions.
How similar studies have gone: While the specific approach of this study may be novel, there is growing interest in the therapeutic effects of light in related fields, suggesting potential for success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Man or woman * Aged 18 years or older * Subject having signed a free and informed consent * Subject affiliated to a social protection scheme Arm 1 :Subjects with primary sleep-wake disorder Arm 2 : subjects presenting a neurological pathology with disorder of the controls of the wake and the sleep Arm 3 : subject presenting a psychiatric pathology pathology with disorder of the controls of the wake and the sleep Arm 4 : subject presenting an ophthalmological pathology with possible alteration of the photoreception and / or phototransduction Arm 5 : subjects with photosensitivity with regulation disorder of sleep and wake Arm 6 : healthy subject Exclusion Criteria: Age-Related Macular Degeneration (AMD) and all maculopathies (retinopathies pigmentosa, macular involvement of diabetes) * Cataract with significant vision loss \<5/10 * Chorioretinal neovascularization * Subject in exclusion period determined by previous or current study * Impossibility to give the subject information enlightened (subject in emergency situation, difficulties of understanding the subject, ...) * Subject under the protection of justice * Subject under guardianship or curatorship * Pregnancy / Breastfeeding
Where it's running
-
University Hospital, Strasbourg, France
Strasbourg, France Recruiting
Study contacts
- Principal investigator: Bourgin Patrice, MD — University Hospital, Strasbourg, France
- Study coordinator: Bourgin Patrice, MD
- Email: pbourgin@unistra.fr
- Phone: 03 88 11 64 30
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Berobenatide in adults with sleep apnea and obesity who don’t use a PAP machine
This study tests berobenatide versus placebo in adults with moderate-to-severe obstructive sleep apnea and overweight or obesity who are not using PAP therapy.
-
Berobenatide in adults with sleep apnea and obesity using a PAP machine
This study tests berobenatide vs. placebo in adults with moderate to severe obstructive sleep apnea and overweight/obesity who use a PAP device.
-
Diaphragmatic Breathing to Improve Sleep in Women with PCOS
This study tests whether diaphragmatic breathing exercises can improve sleep quality for women with PCOS who have sleep problems.
-
CBT-I with Melatonin for Older Adults with Chronic Insomnia
In people aged 60 and over with chronic insomnia, researchers will test whether CBT-I plus nightly melatonin helps sleep better than CBT-I with a placebo or sleep-health education with placebo.
-
Sleep problems, fatigue, and thinking ability in people with MS
We will try to see if sleep problems explain why adults with MS feel very tired and have trouble thinking.
-
Sleep problems and their effects on people with Ménière's disease
This project will see if adults with Ménière's disease who experience debilitating vertigo also have more sleep problems by reviewing patients followed at Strasbourg University Hospital.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.